Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01740843
Other study ID # MECU2012-004
Secondary ID
Status Completed
Phase N/A
First received November 26, 2012
Last updated February 24, 2014
Start date August 2012
Est. completion date June 2013

Study information

Verified date February 2014
Source Hasselt University
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Interventional

Clinical Trial Summary

In this study the effect of tDCS intensity on motor performance and corticospinal (CS) excitability is evaluated. The investigators expect that a positive relationship between current intensity and motor performance/CS excitability.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date June 2013
Est. primary completion date April 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Healthy subjects

Exclusion Criteria:

- Contraindications for tDCS/TMS

- TMS measurements have to be possible

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
transcranial direct current stimulation (tDCS) (NeuroConn DC-stimulator)
The anode is fixed on the primary cortex and the cathode will be fixed on the contralateral supraorbital region.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hasselt University

Outcome

Type Measure Description Time frame Safety issue
Primary Change in motor performance motor performance is assessed using different reaction time paradigms (simple reaction time, choice reaction time). This is done at baseline and immediately after the intervention (30 min after baseline) Baseline and POST (30 min after baseline) intervention No
Primary Change in cortical excitability Cortical excitability is measured using trancranial magnetic stimulation (TMS) measuring muscle evoked potentials (MEPs) at baseline and POST (30 min after baseline). Baseline and POST (30 min after baseline) intervention Yes
See also
  Status Clinical Trial Phase
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Recruiting NCT00789347 - Analysis of Cortical Excitability in Neuropathic Pain N/A
Completed NCT03720665 - Cortical Excitability Changes on the Sensorimotor Cortex Induced by Caffeine Consumption: A TMS Study N/A
Completed NCT02168413 - Cortical Excitability Using Robotised and Neuronavigated Transcranial Magnetic Stimulation
Completed NCT04749745 - Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS Study Early Phase 1
Completed NCT04011670 - Neuroplastic Alterations of the Motor Cortex by Caffeine N/A
Withdrawn NCT03664206 - Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance Spectroscopy
Completed NCT05206162 - TMS-EEG as a Tool to Study the Neuromodulatory Effects of Theta Burst Stimulation N/A
Completed NCT03627364 - Analisys of Cortical Excitability and Motor Function of Post Stroke Patients
Recruiting NCT05517954 - Cortical Excitability in Post-traumatic Epilepsy